An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 207133
Company: PADAGIS ISRAEL

Products on ANDA 207133

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
FLURANDRENOLIDE	FLURANDRENOLIDE	0.05%	LOTION;TOPICAL	Prescription	AT	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 207133

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
08/30/2016	ORIG-1	Approval		STANDARD	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/207133Orig1s000ltr.pdf

Therapeutic Equivalents for ANDA 207133

FLURANDRENOLIDE

LOTION;TOPICAL; 0.05%
TE Code = AT

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
CORDRAN	FLURANDRENOLIDE	0.05%	LOTION;TOPICAL	Prescription	Yes	AT	013790	ALMIRALL
FLURANDRENOLIDE	FLURANDRENOLIDE	0.05%	LOTION;TOPICAL	Prescription	No	AT	207133	PADAGIS ISRAEL

Top